Emotions From Salivary Biomarkers in an Architectural Context (Archi'Motion)

April 9, 2026 updated by: Laurence MOLINA, Sys2Diag

Evaluation of Emotions From Salivary Molecular Biomarkers in an Architectural Context

Architecture influences our well-being. People's behavior and mood changes in different spaces are directly related to the architectural qualities of the built environment. Neuroarchitecture is a discipline that combines neuroscience and architecture to design spaces adapted to the psychological and physiological needs of users. Several studies related to neuroarchitecture have been conducted according to different architectural parameters such as style, natural environment, lighting, color, and sunlight pattern. Recent studies show that emotional states can be evaluated by physiological responses. This physiological regulation comes from the action of enzymes and hormones that represent the activity of the autonomic nervous system. Measuring specific biomarkers through non-invasive biological tests in saliva provides physiological data on an individual's emotional state in response to stimuli, particularly visual or tactile.

Study Overview

Detailed Description

Architecture influences our well-being, and people's behavior and mood changes in different spaces are directly related to the architectural qualities of the built environment. For example, noise and lack of vegetation can generate stress and stress associated with the built environment can even negatively impact life expectancy. Moreover, psychology, and more specifically emotional regulation, plays a fundamental role in how individuals perceive and react to their environment. Emotional regulation is closely linked to the attachment style developed during childhood. Studies have shown that insecure attachment is associated with poorer emotional regulation, which can amplify stress reactions in response to an environment perceived as hostile or inadequate. Neuroarchitecture is a discipline that combines neuroscience and architecture to design spaces adapted to the psychological and physiological needs of users. Its main objective is to create environments that positively influence emotions and well-being, taking into account how our brain perceives and reacts to different elements of space. Several studies related to neuroarchitecture have been conducted according to different architectural parameters such as style, natural environment, lighting, color, and sunlight pattern. These studies generally use tools such as self-assessment scales (e.g., PANAS for affect), functional magnetic resonance imaging (fMRI), electroencephalogram (EEG), and heart rate measurement. These often subjective or indirect methods require trained and/or medical personnel and heavy equipment. In addition, emotions and their regulation are influenced by several sociodemographic factors, including age and the development of the prefrontal cortex, but also gender, socioeconomic level, education level, and cultural context. These factors modulate exposure to stress, the available regulation strategies, and their effectiveness. Life history, particularly early exposure to traumatic events, is also determining. These elements justify the attention paid to inclusion and exclusion criteria in the study (particularly age, gender, cultural context, etc.) to best control these variables. Recent studies show that emotional states (positive and negative) can also be evaluated by physiological responses. This physiological regulation comes from the action of enzymes and hormones that represent the activity of the autonomic nervous system. Thus, several studies using the Trier Social Stress Test (TSST) have highlighted an increase in the concentration of cortisol, DeHydroEpiAndrosterone (DHEA), and salivary alpha-amylase in response to a state of acute stress and anxiety in tested individuals. Glenk et al. studied 40 adults (21 to 34 years old, allergic or not) using measures such as the State-Trait Anxiety Inventory (STAI-S) (20 self-reported items), the Emotion Regulation Questionnaire (ERQ), a visual analog scale of perceived stress (VAS), salivary cortisol measurements, and plasma oxytocin. Izawa et al. analyzed salivary DHEA levels, blood pressure, and heart rate in 33 students with an average age of 22. Van Stegeren et al. measured salivary cortisol and alpha-amylase in 80 adults (men and women) exposed to TSST. Furthermore, an association between positive emotions and a decrease in salivary cortisol has also been described by Lai et al. in 80 adults via a questionnaire and salivary cortisol analysis. Oxytocin modulates the integration of emotional information and interacts with the reward pathway. It is released during positive social interactions and can downregulate stress and heart rate (study of 163 young adults under 35, high school level, no medication, questionnaires, filmed interviews, blood oxytocin measurement). Finally, Kanen et al. showed that fluctuations in serotonin concentration can generate various emotional phenotypes, highlighting the neurobiological impact on emotional regulation. It is therefore essential that participation in architectural exposure is voluntary, as the perception of control is a key factor in modulating the emotional response. Finally, measuring specific biomarkers (enzymes, hormones) through non-invasive biological tests in saliva provides reliable physiological data on an individual's emotional state). These approaches have already been applied to analyze the effects of olfactory stimuli (study of 170 participants, questionnaires, and salivary biomarkers) or architectural. The objective of the proposed research is therefore to measure, in an immersive context (architecture festival), salivary molecular biomarkers known to be linked to emotions. These measurements are intended to objectively measure the influence of an architectural context on physiological parameters related to emotions, while taking into account the psychological, sociodemographic, and developmental factors identified through a dedicated questionnaire.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Montpellier, France, 34184
        • Sys2Diag - Umr9005 Cnrs/Alcen
        • Contact:
        • Contact:
        • Principal Investigator:
          • Laurence MOLINA, PhD
        • Sub-Investigator:
          • Malik KAHLI, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy adult volunteers attending the architectural festival who got exposed and/or got an interaction with an architectural work, with visual, tactile, and/or olfactory stimuli.

Description

Inclusion Criteria:

  • Subject over 18 years old
  • Subject agreeing to follow the study procedures
  • Subject capable of understanding the purpose, nature, and methodology of the study
  • Subject affiliated with a French social security scheme or beneficiary of such a scheme.

Exclusion Criteria:

  • Subject not affiliated with a French Social Security scheme or not a beneficiary of such a scheme
  • Subject deprived of liberty, protected adult, vulnerable person, or minor
  • Subject with proven or suspected chronic infectious disease that could pose a risk of contamination during sample handling (laboratories not equipped to handle this type of sample)
  • Subject with a deficiency (vision, anosmia) preventing proper interaction with the architectural work
  • Subject presenting signs of active oral inflammation, advanced periodontitis, or severe gingivitis
  • Subject suffering from Gougerot-Sjögren syndrome (dry syndrome) or mouth cancer
  • Pregnant or breastfeeding women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ARM VT
30 subjects who will be exposed to an architectural work offering visual and tactile stimulations.
Saliva of participants will be sampled for analysis of biomarkers of interest (DHEA, oxytocin, cortisol, alpha-amylase, serotonin, and dopamine) using enzymatic dosage methods or ELISA-type methods carried out using commercial kits.
ARM O
30 subjects who will be exposed to a second architectural work offering visual, tactile, and olfactory stimulations.
Saliva of participants will be sampled for analysis of biomarkers of interest (DHEA, oxytocin, cortisol, alpha-amylase, serotonin, and dopamine) using enzymatic dosage methods or ELISA-type methods carried out using commercial kits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the variation of salivary biomarkers, which may be linked to emotions (positive or negative), before and after interaction with an architectural work.
Time Frame: 2 years
Evaluate the variation of salivary biomarkers, which may be linked to emotions (positive or negative), before and after interaction with an architectural work. This exposure includes a combination of visual, tactile, and/or olfactory stimuli.
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identify a salivary molecular biomarker signature linked to an emotional profile following exposure to an architectural site.
Time Frame: 2 years
Identify, from measurements of alpha-amylase, cortisol, DHEA, oxytocin, serotonin, and dopamine, one or more profile(s) of biomarker concentration variation, which would differentiate the emotions felt following exposure to an architectural site. These combinations of biomarkers could identify an emotion profile linked to a biomarker signature.
2 years
Compare the identified molecular biomarker signatures between the studied architectural sites (different types of visual, tactile, or olfactory stimuli).
Time Frame: 2 years
Compare the different combinations of biomarker variations identified previously according to the two studied architectural sites. Indeed, since the two sites are architecturally different, the identified signatures could be different depending on the sites.
2 years
Establish correlations between the identified biomarker signatures linked to emotional profiles and sociodemographic and developmental data.
Time Frame: 2 years
Compare the biomarker signatures measured after stimulation and the sociodemographic and developmental data to establish correlations between the stimuli, the emotions felt, and age, gender, etc.
2 years
Evaluate the homogeneity of the emotional physiological response following exposure to an architectural site.
Time Frame: 2 years
Analyze the dispersion of the data obtained for each architectural site according to the day, age, gender, etc.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Laurence MOLINA, PhD, Sys2Diag

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 9, 2026

Primary Completion (Estimated)

June 14, 2026

Study Completion (Estimated)

June 14, 2028

Study Registration Dates

First Submitted

March 26, 2026

First Submitted That Met QC Criteria

March 26, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-A00909-40
  • 25.01443.000493#1 (Other Identifier: Comité de Protection des Personnes (French Ethics committee))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotions

Clinical Trials on Bio-fluid analysis for the measurement of salivary biomarkers linked to emotions

Subscribe